New Post has been published on Stock Markets Daily
New Post has been published on http://www.stockmarketsdaily.com/fundamental-look-carefusion-nysecfn/8724/
A Fundamental Look at CareFusion (NYSE:CFN)
(adsbygoogle = window.adsbygoogle || []).push();
We look at CareFusion (NYSE:CFN) a company in the Medical Instruments & Supplies industry being focused on by many investors, to assess if it provides value for investors considering buying or selling it. Currently CareFusion is trading at $59.70 after moving up 0.15% in the previous day of trading.
CFN [Trend Analysis] is trading with a trailing 12 month P/E multiple of 25.30 and an estimated forward P/E multiple of 20.37. The stock has an estimated 5 year annual growth of 10.50% and a PEG multiple of 2.41.
Rather than the usual Price to Earnings (P/E) multiple method, we use a slightly different method to assess if CareFusion is potentially a value buy for investors, the PEG ratio (P/E to growth). This PEG multiple takes into account the expected long term growth in earnings of the company rather than merely the growth for one earnings period ahead as forward P/E does.
That is to say, P/E simply doesn’t account for the long term prospects of CFN. As a rule of thumb, a stock with a PEG of between 0 and 1 is usually considered to be underpriced, between 1 and 2 to be at fair value and over 2 to be overpriced. Based on the PEG ratio of CFN being 2.41, we consider CareFusion to likely be overpriced.
This analysis means that value buyers who do not currently hold CareFusion (NYSE:CFN) should not consider buying and investors currently holding the stock should consider selling.
The mean analyst 12 month target price for CareFusion (NYSE:CFN) is currently $57.17 or 4.24% below the current price. Additionally, the stock has been as high as $60.08 and as low as $37.76 in the last 52 weeks. Analysts are estimating that CFN will report earnings per share of $0.84 next quarter.